Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NTLA

Recent news which mentions NTLA

< Previous 1 2 3 Next >
Up 1,000% in 5 Years? Here Are 3 Stocks That Can Run That High
Tickers DOCS NTLA TMDX
Tags Recent Press Releases TMDX NTLA
From Motley Fool
Intellia's Gene-Editing Candidate Shows Durability In ATTR Amyloidosis
Tickers NTLA REGN
Tags General Benzinga Briefs
From Benzinga
BMO Initiates Coverage On This Gene Editing Spearhead
Tickers EDIT NTLA
Tags Health Care Biotech News
From Benzinga
Analyst Ratings for Intellia Therapeutics
Tickers NTLA
Tags Analyst Ratings NTLA BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2022
Tickers AIRS AJG APLE AWI
Tags DSEY APLE OMEX
From Benzinga
Analyst Ratings for Intellia Therapeutics
Tickers NTLA
Tags NTLA Analyst Ratings Market News
From Benzinga
Why Editas Medicine's Shares Fell 28.9% This Week
Tickers CRSP EDIT NTLA
Tags ^IXIC NTLA Market News
From Motley Fool
10 Biggest Price Target Changes For Monday
Tickers CI EPAM GH K
Tags RLMD EPAM Price Target
From Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
Tickers ABUS AGIO ALDX ARGX
Tags INCY SGMO CHRS
From Benzinga
Earnings Preview For Intellia Therapeutics
Tickers NTLA
Tags NTLA Benzinga Market News
From Benzinga
How To Attend Intellia Therapeutics Q1 2022 Earnings Conference Call
Tickers NTLA
Tags BZI/CONF NTLA Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022
Tickers ACHR ALL AM ARVN
Tags JOBY BEAM Intraday Update
From Benzinga
4 Analysts Have This to Say About Intellia Therapeutics
Tickers NTLA
Tags Market News BZI/AAR Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
Tickers HLBZ HNST HYFM HYRE
Tags TYRA Z OMGA
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Tickers ACLX ADVM AFCG ALLK
Tags AMSC PRQR VLD
From Benzinga
3 Top Biotech Stocks Ready for a Bull Run
Tickers BNTX NTLA PFE REGN
Tags SNY Market News PFE
From Motley Fool
3 Ominous Reasons to Avoid This Biotech Pioneer
Tickers CRSP EDIT NTLA
Tags NTLA Recent Press Releases EDIT
From Motley Fool
CRISPR Stocks Are Huge -- Here's Why They'll Get Even Bigger by 2030
Tickers CRSP EDIT NTLA VRTX
Tags CRSP EDIT Market News
From Motley Fool
Who Benefits From Amazon's Stock Split?
Tickers AAPL AMZN BMBL CMG
Tags CRSP NTLA MSFT
From Motley Fool
FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials
Tickers BLUE NTLA
Tags FDA General gene therapy
From Benzinga
Here's How Much $100 Invested In Intellia Therapeutics 5 Years Ago Would Be Worth Today
Tickers NTLA
Tags Earnings BZI/POD Market News
From Benzinga
Intellia's CRISPR-Engineered Cell Therapy Receives FDA Orphan Drug Tag For Bone Marrow Cancer
Tickers NTLA
Tags FDA General Briefs
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2022
Tickers AAL AU AUGX AZUL
Tags PM ESRT X
From Benzinga
63 Biggest Movers From Yesterday
Tickers AEO ANGH APCX ATNX
Tags NCNA CAN Penny Stocks
From Benzinga
Is Intellia a Good Gene-Editing Stock to Buy Now?
Tickers NTLA REGN
Tags Recent Press Releases NTLA REGN
From Motley Fool
Can Biotech Stocks Provide Crypto-Like Growth for Your Portfolio?
Tickers BNTX BTC CRSP ETH
Tags BNTX MRNA Recent Press Releases
From Motley Fool
80 Biggest Movers From Yesterday
Tickers ALBO AMBA AMLX ANPC
Tags SFT VEON ANPC
From Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
Tickers AMBA AREB ATRA ATXI
Tags GFAI EHTH VRTV
From Benzinga
Analyst Ratings For Intellia Therapeutics
Tickers NTLA
Tags NTLA Analyst Ratings Market News
From Benzinga
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
Tickers ABBV AMRN AMRS AVID
Tags AMRS HZNP LEGN
From Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.